ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday,
UPDATE – LB Pharmaceuticals Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
About LB Pharmaceuticals LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia. The company’s lead candidate,
Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference
A live webcast of the presentation will be available on the “Investors” section of the Editas Medicine website at An archived replay will be available on the website for approximately 30 days following the presentation.
Actio Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Actio Biosciences is leveraging advances in precision medicine to develop new therapeutics that target shared genetics in rare and common diseases—bringing meaningful medicines from one to many. Applying its expertise in genetics,
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
No. 1 / 2025Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13thCopenhagen, Denmark,
Hosted on MSN20h
ResMed Inc. Reports Change in Beneficial Ownership
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an update. ResMed Inc.
ResMed Inc. stock rises Friday, outperforms market
Shares of ResMed Inc. RMD advanced 1.40% to $231.67 Friday, on what proved to be an all-around positive trading session for ...
ResMed Chairman Emeritus Disposes Shares in Planned Transaction
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
Pharmabiz9h
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...
ResMed Inc. stock falls Thursday, still outperforms market
Shares of ResMed Inc. RMD dropped 0.09% to $228.48 Thursday, on what proved to be an all-around rough trading session for the ...
Yahoo Finance3d
ResMed Gains 37.8% in a Year: What's Driving the Stock?
ResMed Inc. RMD has witnessed strong momentum in the past year. Shares of the company have risen 37.8% compared with 10.7% growth of the industry during the same time frame. The S&P 500 composite ...
Stockhead on MSN1d
Hot Money Monday: Analyst spots two potential long-term ASX winners
Morningstar’s analyst picks ResMed and PWR as top ASX long-term plays, with ResMed eyeing sleep market domination.
Resmed Inc Director Plans Significant Stock Sale
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss Our New Year's ...
Declining Stock and Solid Fundamentals: Is The Market Wrong About ResMed Inc. (NYSE:RMD)?
ResMed (NYSE:RMD) has had a rough month with its share price down 5.8%. However, stock prices are usually driven by ...